Literature DB >> 24607968

Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis.

Travis Burns1, Laird Miers, Jie Xu, Alan Man, Monica Moreno, David Pleasure, Peter Bannerman.   

Abstract

We provide evidence of cortical neuronopathy in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis, an established model of chronic multiple sclerosis. To investigate phenotypic perturbations in neurons in this model, we used apoptotic markers and immunohistochemistry with antibodies to NeuN and other surrogate markers known to be expressed by adult pyramidal Layer V somas, including annexin V, encephalopsin, and Emx1. We found no consistent evidence of chronic loss of Layer V neurons but detected both reversible and chronic decreases in the expression of these markers in conjunction with evidence of cortical demyelination and presynaptic loss. These phenotypic perturbations were present in, but not restricted to, the neocortical Layer V. We also investigated inflammatory responses in the cortex and subcortical white matter of the corpus callosum and spinal dorsal funiculus and found that those in the cortex and corpus callosum were delayed compared with those in the spinal cord. Inflammatory infiltrates initially included T cells, neutrophils, and Iba1-positive microglia/macrophages in the corpus callosum, whereas only Iba1-positive cells were present in the cortex. These data indicate that we have identified a new temporal pattern of subtle phenotypic perturbations in neocortical neurons in this chronic multiple sclerosis model.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24607968      PMCID: PMC4229074          DOI: 10.1097/NEN.0000000000000058

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  55 in total

1.  Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.

Authors:  M A Lee; A M Blamire; S Pendlebury; K H Ho; K R Mills; P Styles; J Palace; P M Matthews
Journal:  Arch Neurol       Date:  2000-01

2.  Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo.

Authors:  Paola Arlotta; Bradley J Molyneaux; Jinhui Chen; Jun Inoue; Ryo Kominami; Jeffrey D Macklis
Journal:  Neuron       Date:  2005-01-20       Impact factor: 17.173

3.  Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice.

Authors:  P G Bannerman; A Hahn; S Ramirez; M Morley; C Bönnemann; S Yu; G-X Zhang; A Rostami; D Pleasure
Journal:  Brain       Date:  2005-05-18       Impact factor: 13.501

4.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

5.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

6.  An animal model of cortical and callosal pathology in multiple sclerosis.

Authors:  Mario Mangiardi; Daniel K Crawford; Xiaoyu Xia; Sienmi Du; Rebecca Simon-Freeman; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2010-11-10       Impact factor: 6.508

7.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

8.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

9.  IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.

Authors:  Eunyoung Lee; Sarah Chanamara; David Pleasure; Athena M Soulika
Journal:  J Neuroinflammation       Date:  2012-01-16       Impact factor: 8.322

10.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.

Authors:  Catherine M Dalton; Declan T Chard; Gerard R Davies; Katherine A Miszkiel; Dan R Altmann; Kryshani Fernando; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  Brain       Date:  2004-03-03       Impact factor: 13.501

View more
  1 in total

1.  Copper chelation and autoimmunity differentially impact myelin in the hippocampal-prefrontal circuit.

Authors:  Mara Nickel; Farida Eid; Peter Jukkola; Chen Gu
Journal:  J Neuroimmunol       Date:  2019-06-20       Impact factor: 3.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.